NA
CLX icon

Navellier & Associates’s Clorox CLX Stock Holding History

Navellier & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Buy
6,055
+1,639
+37% +$157K 0.05% 233
2026
Q1 		$458K Sell
4,416
-8
-0.2% -$907 0.05% 225
2025
Q4 		$446K Sell
4,424
-1,352
-23% -$147K 0.05% 230
2025
Q3 		$712K Buy
5,776
+1,161
+25% +$144K 0.07% 215
2025
Q2 		$554K Buy
4,615
+10
+0.2% +$1.33K 0.07% 202
2025
Q1 		$637K Buy
+4,605
New +$703K 0.09% 185
2021
Q4 		– Sell
-1,346
Closed -$223K – 320
2021
Q3 		$223K Hold
1,346
– – 0.03% 288
2021
Q2 		$242K Sell
1,346
-12,083
-90% -$2.21M 0.04% 269
2021
Q1 		$2.59M Sell
13,429
-25,611
-66% -$4.93M 0.47% 71
2020
Q4 		$7.88M Buy
39,040
+2,521
+7% +$522K 1.43% 13
2020
Q3 		$7.67M Sell
36,519
-27,359
-43% -$6.09M 1.67% 7
2020
Q2 		$14M Buy
63,878
+59,003
+1,210% +$11.8M 3.33% 2
2020
Q1 		$845K Buy
+4,875
New +$805K 0.2% 100
2016
Q4 		– Sell
-84,351
Closed -$10.6M – 280
2016
Q3 		$10.6M Sell
84,351
-8,584
-9% -$1.12M 1.51% 14
2016
Q2 		$12.9M Sell
92,935
-49,752
-35% -$6.45M 1.92% 12
2016
Q1 		$18M Buy
142,687
+26,073
+22% +$3.31M 2.34% 11
2015
Q4 		$14.8M Buy
116,614
+114,009
+4,377% +$14.2M 1.63% 27
2015
Q3 		$301K Buy
2,605
+156
+6% +$17.5K 0.03% 217
2015
Q2 		$255K Buy
2,449
+359
+17% +$38.7K 0.02% 303
2015
Q1 		$231K Sell
2,090
-389
-16% -$42.2K 0.02% 315
2014
Q4 		$258K Sell
2,479
-8
-0.3% -$800 0.01% 278
2014
Q3 		$239K Buy
2,487
+52
+2% +$4.7K 0.01% 289
2014
Q2 		$223K Sell
2,435
-667
-22% -$59.7K 0.01% 294
2014
Q1 		$273K Sell
3,102
-386,829
-99% -$34M 0.01% 269
2013
Q4 		$36.2M Sell
389,931
-44,447
-10% -$4M 1.63% 35
2013
Q3 		$35.5M Sell
434,378
-8,020
-2% -$677K 1.05% 53
2013
Q2 		$36.8M Buy
+442,398
New +$38.1M 1.75% 29

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Navellier & Associates's CLX Position: Q2 2026 in Review

Navellier & Associates increased its Clorox (CLX) stake by 37% in Q2 2026, buying an estimated $157K and bringing the position to 6,055 shares worth $578K. The position accounts for 0.05% of the portfolio, ranked #233.

Navellier & Associates first reported a position in CLX in Q2 2013 and has held it in 27 quarters since. The position peaked at $36.8M in Q2 2013. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Navellier & Associates held 6,055 shares of Clorox worth $578K as of Q2 2026.
  • Navellier & Associates bought 1,639 Clorox shares in Q2 2026, an estimated $157K.
  • Clorox made up 0.05% of Navellier & Associates's portfolio in Q2 2026, its #233 holding.
  • Navellier & Associates first reported a position in Clorox in Q2 2013 and has held it in 27 quarters since.
  • Navellier & Associates's Clorox position peaked at $36.8M in Q2 2013.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Navellier & Associates's 13F filing for Q2 2026, filed 4 Aug 2026.